Lack of evidence for use of heparin-bonded grafts in access surgery: a meta-analysis

Semin Vasc Surg. 2016 Dec;29(4):192-197. doi: 10.1053/j.semvascsurg.2016.08.003. Epub 2016 Aug 11.

Abstract

The aim of this study was to evaluate the efficacy of heparin-bonded vascular grafts to offer improved outcomes compared with standard prosthetic grafts in access surgery. A systematic review and meta-analysis was performed and eight studies (seven observational studies and one randomized controlled trial) were included. The pooled 6-month and 1-year primary patency was not significantly different between heparin-bonded arteriovenous (AV) grafts and standard prosthetic AV grafts in seven studies reporting on 1,209 access procedures. The assisted primary patency and secondary patency at 1-year was not significantly different either. Heparin-bonded AV grafts offer no distinct advantage over standard prosthetic AV grafts and their preferential use in access surgery cannot be recommended based on the available evidence.

Publication types

  • Meta-Analysis
  • Review
  • Systematic Review

MeSH terms

  • Anticoagulants / administration & dosage*
  • Anticoagulants / adverse effects
  • Arteriovenous Shunt, Surgical / adverse effects
  • Arteriovenous Shunt, Surgical / instrumentation*
  • Blood Vessel Prosthesis Implantation / adverse effects
  • Blood Vessel Prosthesis Implantation / instrumentation*
  • Blood Vessel Prosthesis*
  • Chi-Square Distribution
  • Coated Materials, Biocompatible*
  • Evidence-Based Medicine*
  • Graft Occlusion, Vascular / etiology
  • Graft Occlusion, Vascular / physiopathology
  • Graft Occlusion, Vascular / therapy
  • Heparin / administration & dosage*
  • Heparin / adverse effects
  • Humans
  • Odds Ratio
  • Renal Dialysis*
  • Renal Insufficiency, Chronic / therapy*
  • Risk Factors
  • Time Factors
  • Treatment Outcome
  • Vascular Patency

Substances

  • Anticoagulants
  • Coated Materials, Biocompatible
  • Heparin